Infection and Drug Resistance

Infection and Drug Resistance期刊基本信息

Infection and Drug Resistance
  • 简称:INFECT DRUG RESIST
  • 大类:医学
  • 小类:传染病学
  • ISSN:1178-6973
  • IF值:3
  • 年文章数:58
  • 审稿速度:
  • 平均录用比例:
投稿咨询

官方网站:

投稿网址:

PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1178-6973%5BISSN%5D

Infection and Drug Resistance中文简介

目标和范围总编:苏雷什·安东尼教授《感染与耐药性》是一份国际、同行评议的开放获取期刊,重点关注感染(细菌、真菌和病毒)的最佳治疗,以及制定和制定预防策略,以最大限度地减少耐药性的发展和传播。该杂志特别关注抗生素耐药性的流行病学以及耐药性在医院和社区的发展和扩散机制。特别是,研究和临床开发新的抗感染作用机制和现有治疗方法的最佳使用将受到重视。其他领域包括感染的诊断和早期检测,蛋白质组学和基因组学研究,以确定耐药生物体表面蛋白的特征,以及教育和感染控制策略。随着与产生耐药性相关的死亡率、发病率和医疗成本的增加,旨在改善结果和患者依从性和满意度的研究、临床研究和规划将得到优先考虑。该杂志的特点是快速报告的审查,指南,原始研究和临床研究的所有领域的感染和耐药性。

Infection and Drug Resistance英文简介

Aims and ScopeEditor-in-Chief: Professor Suresh AntonyInfection and Drug Resistance is an international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance. The journal is specifically concerned with the epidemiology of antibiotic resistance and the mechanisms of resistance development and diffusion in both hospitals and the community. In particular, research and clinical development of novel mechanism of action anti-infectives and the optimal use of existing therapies will be highlighted. Other areas of coverage include diagnostic and early detection of infection, proteomic and genomic studies to characterize surface proteins in resistant organisms, and educational and infection control strategies. With increased mortality, morbidity and healthcare costs associated with developing resistance, research, clinical studies and programs designed to improve outcomes and patient adherence and satisfaction will be given priority. The journal is characterized by the rapid reporting of reviews, guidelines, original research and clinical studies in all areas of infection and drug resistance.

国际期刊推选 论文翻润预审发表!

选择丰富服务快速通过率高一键快速领取私人专属发表方案!

* 请认真填写需求信息,学术顾问24小时内与您取得联系。